Cargando…
Identification of a Selective RelA Inhibitor Based on DSE-FRET Screening Methods
Nuclear factor-κB (NF-κB) is an important transcription factor involved in various biological functions, including tumorigenesis. Hence, NF-κB has attracted attention as a target factor for cancer treatment, leading to the development of several inhibitors. However, existing NF-κB inhibitors do not...
Autores principales: | Shiroma, Yoshitomo, Fujita, Go, Yamamoto, Takuya, Takahashi, Ryou-u, Kumar, Ashutosh, Zhang, Kam Y. J., Ito, Akihiro, Osada, Hiroyuki, Yoshida, Minoru, Tahara, Hidetoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734590/ https://www.ncbi.nlm.nih.gov/pubmed/33266352 http://dx.doi.org/10.3390/ijms21239150 |
Ejemplares similares
-
DSE-FRET: A new anticancer drug screening assay for DNA binding proteins
por: Miyagi, Toru, et al.
Publicado: (2014) -
Targeting DNA binding proteins for cancer therapy
por: Shiroma, Yoshitomo, et al.
Publicado: (2020) -
Subinhibitory Concentrations of Bacteriostatic Antibiotics Induce relA-Dependent and relA-Independent Tolerance to β-Lactams
por: Kudrin, Pavel, et al.
Publicado: (2017) -
Influence of the relA gene on ribosome frameshifting
por: Masucci, J., et al.
Publicado: (2002) -
Identification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells conditionally expressing RelA
por: Kochupurakkal, Bose S., et al.
Publicado: (2015)